Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inhibitor Therapeutics, Inc. | Chief Executive Officer, Executive Chairman of the Board, Director, 10%+ Owner | Common Stock | 85.6M | Dec 13, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INTI | Inhibitor Therapeutics, Inc. | Dec 13, 2022 | 0 | $0 | 3 | Dec 22, 2022 | Chief Executive Officer, Executive Chairman of the Board, Director, 10%+ Owner |